Chinese herbal medicine may improve outcomes after STEMI
Por um escritor misterioso
Descrição
CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and
:max_bytes(150000):strip_icc()/what-are-adaptogens-4685073-primary-recirc-f5ef8698bc704b96ba54710b64fd7a0f.jpg)
Adaptogens: Types and Health Benefits
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Traditional Chinese medicine Tongxinluo may improve heart health
Signaling pathways and targeted therapy for myocardial infarction
Chinese Medicine Johns Hopkins Medicine
High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality
The traditional Chinese medicine that could become 'key treatment' for heart attacks, as study finds it lowers inflammation without adverse effects
Long-term cardiovascular outcomes of COVID-19
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI
Progress in traditional Chinese medicine and natural extracts for the treatment of lupus nephritis - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
